Citations
1294 citation(s) found for "Kumar, Shaji".
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Voorhees, Peter M. , Hurd, David D., Rodriguez, Cesar , Korde, Neha , Safah, Hana, Bueno, Orlando F. , Pumford, Neil R., Rosenberg, Tanya S, Pothacamury, Rajvineeth Kumar, Polepally, Akshanth R. , Talati, Chetasi, Vij, Ravi , Kumar, Shaji , D’Souza, Anita , Weisel, Katja C , Teipel, Raphael , Chung, Alfred , Tuchman, Sascha Alexander , Pumford, Neil, Ross, Jeremy A. , Lee, Shane , Jin, Ziyi , Talati, Chetasi
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4401-4404
Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma
Murray, David , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L., Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Claveau, Jean‐Sébastien , Dispenzieri, Angela , Binder, Moritz , Buadi, Francis K. , Dingli, David , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348
Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study
Usmani, Saad Z. , Plesner, Torben , Hulin, Cyrille , Goldschmidt, Hartmut , Venner, Christopher P. , Tiab, Mourad, Macro, Margaret , Leleu, Xavier , Pei, Huiling , Krevvata, Maria, Carson, Robin, Borgsten, Fredrik, Kumar, Shaji , Usmani, Saad , Moreau, Philippe , Facon, Thierry T.F. , Bahlis, Nizar Jacques , Raje, Noopur , Orlowski, Robert Z. , Basu, Supratik , Nahi, Hareth , Quach, Hang , O’Dwyer, Michael , Perrot, Aurore , Weisel, Katja C , Frenzel, Laurent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7297-7300
Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Kumar, Shaji , Liedtke, Michaela , Mailankody, Sham , Limones, Josiana, Das, Sharmila , Thorpe, Jerill , Cacciatore, Jonathan J. , Navarro, Garnet, Koegel, Ashley K., Burgess, Michael R., Hege, Kristen , Costa, Luciano J. , Atrash, Shebli , Kaur, Gurbakhash , Derman, Benjamin A. , Bergsagel, P. Leif , McCarthy, Philip L. , Chen, Yanping , Richard, Shambavi
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1360-1362
Universal Updated Phase 1 Data Highlights Role of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma
Mailankody, Sham , Matous, Jeffrey, Liedtke, Michaela , Sidana, Surbhi , Oluwole, Olalekan O. , Cruz, José C. , Nath, Rajneesh , Anwer, Faiz , Rossi, Adriana, Htut, Myo, Malik, Shahbaz A. , Ghatta, Srinivas, Dillon, Myles, Ying, Wendy , Navale, Lynn, Karski, Erin E., Balakumaran, Arun, Kumar, Shaji , Sidana, Surbhi , Oluwole, Olalekan O , Anwer, Faiz , Mohan, Meera , Rossi, Adriana , Htut, Myo
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4620-4622
Variation in the Immune Tumor Microenvironment in Relation to Self-Reported Race in Individuals with Multiple Myeloma
Sharma, Neeraj , Tang, Hongwei , Yan, Huihuang , Tian, Shulan , Shivaram, Suganti, Kourelis, Taxiarchis , Kumar, Shaji , Sharma, Neeraj , Tang, Hongwei, Baughn, Linda B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4209-4210
Current Testing Practices for t(11;14) Rearrangements in Patients with Newly Diagnosed Multiple Myeloma in the United States
Mearns, Elizabeth S. , Nixon, Michael , Chopra, Vivek S. , Girvan, Allicia, Cornell, Robert F. , Saxena, Jayeta, Slifko, Bethany M., Clark, Jordan F. , Kumar, Shaji , Baughn, Linda B. , Slifko, Bethany Michelle, Clark, Jordan
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10114-10115
Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis
Kumar, Shaji , Plesner, Torben , Hulin, Cyrille , Venner, Christopher P. , Tiab, Mourad, Macro, Margaret , Leleu, Xavier , Pei, Huiling , Carson, Robin, Borgsten, Fredrik, Goldschmidt, Hartmut , Facon, Thierry T.F. , Weisel, Katja C , Usmani, Saad Z. , Moreau, Philippe , Orlowski, Robert Z. , Bahlis, Nizar Jacques , Basu, Supratik , Nahi, Hareth , Quach, Hang , O’Dwyer, Michael , Perrot, Aurore , Raje, Noopur , Frenzel, Laurent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10133-10136
Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes
Kumar, Shaji , LaPlant, Betsy, Asmus, Erik, Thompson, Melanie , Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Buadi, Francis K. , Gonsalves, Wilson I. , Muchtar, Eli , Dingli, David , Thompson, Melanie Ann, Go, Ronald S. , Dispenzieri, Angela , Leung, Nelson , Binder, Moritz , Rajkumar, S. Vincent , Gertz, Morie A.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10142-10143
Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide
Goel, Utkarsh , Charalampous, Charalampos , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L. , Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Binder, Moritz , Buadi, Francis K. , Dingli, David , Dispenzieri, Angela , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999